Endexx Announces Patient Enrollment in Clinical Study of Proprietary CBD Capsule Formulation for Treatment of … – SYS

CAVE CREEK, AZ — (Marketwired) — 06/22/16 — Endexx Corporation (OTC PINK: EDXC), a provider of innovative hemp derived phyto-nutrients and nutritional health products, announced today that approximately 40 patients have enrolled in an adaptive clinical study to test the efficacy of its proprietary CBD capsule in alleviating symptoms

... read more at: http://news.sys-con.com/node/3854385